Amgen (NASDAQ: AMGN) today announced the launch of a new seven-year environmental sustainability plan, which includes a commitment to achieve carbon neutrality, while also reducing water use by 40% and waste disposed by 75%.
"As a science-based company with a mission to serve patients, we understand the profound impact that climate change is having on human health around the world," said Robert A. Bradway, chairman and chief executive officer at Amgen. "Our new commitments expand on our previous achievements and drive Amgen's continued leadership on environmental sustainability that will benefit our patients, staff, shareholders and communities."
Since 2007, Amgen has implemented projects resulting in a 33% reduction in carbon emissions, a 30% reduction in water use and a 28% reduction in waste. These reductions were achieved even as the company increased production capacity, expanded our presence to more than 100 countries and grew revenues significantly.
Amgen will invest more than $200 million to achieve these 2027 environmental commitments, and expects that such investment will help us to become not just more environmentally sustainable but also more flexible and productive, resulting in reductions in operating costs from such efficiencies over the same period. The company will focus on the use of innovative technologies to significantly reduce carbon emissions from Amgen-owned operations, as well as on sourcing renewable energy. For example, Amgen's newest biomanufacturing plant in Singapore generates 70% less carbon than traditional biomanufacturing facilities. The company has built a second such plant in Rhode Island.
Where carbon emissions cannot be eliminated from its operations, Amgen will invest in sustainability projects that sequester or avoid greenhouse gas emissions. In addition, Amgen will engage with its suppliers to assist and encourage carbon reductions throughout its value chain.
More information about Amgen's environmental plans can be found here.